Peng Xue Selected Research

Metal-Organic Frameworks

1/2022	Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy.
2/2015	Nano metal-organic framework (NMOF)-based strategies for multiplexed microRNA detection in solution and living cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peng Xue Research Topics

Disease

116	Neoplasms (Cancer) 03/2024 - 02/2009
17	Inflammation (Inflammations) 02/2024 - 04/2011
14	Neoplasm Metastasis (Metastasis) 01/2024 - 04/2014
9	Hypoxia (Hypoxemia) 12/2023 - 01/2012
9	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2011
8	Pain (Aches) 02/2022 - 04/2013
8	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2012
6	Osteoporosis 01/2023 - 12/2016
6	Pancreatic Neoplasms (Pancreatic Cancer) 07/2021 - 04/2014
5	Periodontitis 10/2023 - 05/2014
5	Infections 03/2023 - 01/2009
5	Hyperthermia 01/2022 - 01/2018
5	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2003
5	Insulin Resistance 01/2016 - 04/2011
4	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 08/2015
4	Urinary Bladder Neoplasms (Bladder Cancer) 10/2017 - 01/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 08/2012
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 01/2021
3	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 01/2012
3	Shock 01/2022 - 01/2020
3	Starvation 01/2022 - 01/2020
3	Oral Lichen Planus 01/2021 - 01/2020
3	Hepatocellular Carcinoma (Hepatoma) 09/2019 - 01/2003
3	Skin Neoplasms (Skin Cancer) 01/2013 - 01/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2024 - 02/2024
2	Body Weight (Weight, Body) 02/2024 - 11/2023
2	Carcinoma (Carcinomatosis) 10/2023 - 03/2023
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2023 - 01/2023
2	Carcinogenesis 03/2023 - 01/2018
2	Thrombosis (Thrombus) 01/2023 - 04/2019
2	Necrosis 05/2022 - 10/2018
2	Atrophy 02/2022 - 01/2021
2	Muscular Atrophy (Muscle Atrophy) 02/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2003
18	ProdrugsIBA 01/2022 - 11/2016
15	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2008
12	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2015
11	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 01/2018
11	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 04/2011
10	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021 - 10/2018
10	MicellesIBA 01/2020 - 09/2017
8	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2021
7	Oxygen (Dioxygen)IBA 01/2022 - 11/2019
6	LipidsIBA 02/2024 - 08/2012
6	Therapeutic UsesIBA 01/2021 - 01/2018
6	ferric ferrocyanide (Prussian blue)FDA Link 03/2019 - 01/2015
6	ArsenicIBA 02/2013 - 01/2011
5	HydrogelsIBA 10/2023 - 12/2018
5	DisulfidesIBA 02/2023 - 01/2016
5	Glutathione (Reduced Glutathione)IBA 01/2023 - 01/2016
5	AcidsIBA 10/2021 - 11/2017
5	phytochlorinIBA 01/2020 - 10/2018
5	Insulin (Novolin)FDA Link 01/2020 - 04/2011
4	polyethylene glycol polyethyleneimine nanogelIBA 01/2023 - 02/2021
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2023 - 01/2018
4	MicroRNAs (MicroRNA)IBA 01/2022 - 02/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 04/2017
4	PolymersIBA 09/2021 - 09/2017
4	CamptothecinIBA 02/2021 - 11/2017
4	Photosensitizing Agents (Photosensitizers)IBA 01/2021 - 01/2019
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020 - 02/2017
4	AntigensIBA 04/2014 - 03/2013
3	RNA (Ribonucleic Acid)IBA 04/2024 - 05/2017
3	SaponinsIBA 02/2024 - 02/2019
3	Peptides (Polypeptides)IBA 01/2023 - 01/2015
3	AntioxidantsIBA 01/2023 - 08/2012
3	SolutionsIBA 01/2023 - 02/2015
3	Amino Acids FDA Link 03/2022 - 05/2014
3	Fibroins (Fibroin)IBA 01/2022 - 01/2019
3	Liraglutide FDA Link 10/2020 - 10/2019
3	Sulfides (Thioethers)IBA 06/2020 - 01/2019
3	CopperIBA 06/2020 - 01/2019
3	CyclodextrinsIBA 11/2019 - 08/2018
3	Glycoproteins (Glycoprotein)IBA 01/2019 - 01/2017
3	IsotopesIBA 02/2017 - 05/2014
3	CarbohydratesIBA 04/2014 - 02/2014
3	Carcinoembryonic AntigenIBA 04/2014 - 02/2014
2	Levodopa (L Dopa)FDA LinkGeneric 04/2024 - 02/2024
2	Antimycin AIBA 04/2024 - 02/2024
2	CatalaseIBA 03/2024 - 12/2023
2	GinsenosidesIBA 02/2024 - 04/2017
2	Bevacizumab (Avastin)FDA Link 01/2024 - 04/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 10/2018
2	manganese oxide (hausmannite)IBA 11/2023 - 01/2019
2	Long Noncoding RNAIBA 03/2023 - 01/2021
2	Glucose OxidaseIBA 02/2023 - 01/2020
2	Mannose ReceptorIBA 01/2023 - 01/2022
2	Caspase 3 (Caspase-3)IBA 01/2023 - 01/2020
2	Granzymes (Granzyme)IBA 01/2023 - 02/2009
2	InterferonsIBA 10/2022 - 12/2021
2	Biocompatible Materials (Biomaterials)IBA 10/2022 - 01/2020

Therapy/Procedure

74	Therapeutics 12/2023 - 01/2015
30	Drug Therapy (Chemotherapy) 01/2024 - 01/2012
13	Precision Medicine 01/2023 - 11/2017
13	Lasers (Laser) 01/2022 - 03/2012
10	Immunotherapy 10/2023 - 01/2020
10	Photochemotherapy (Photodynamic Therapy) 01/2021 - 10/2018
7	Photothermal Therapy 01/2022 - 01/2015
4	Induced Hyperthermia (Thermotherapy) 01/2022 - 01/2020
3	Aftercare (After-Treatment) 02/2022 - 04/2019